AUTOIMMUNE ARTHRITIS DISEASE/PROTECTION BY T CELL CLONES

NIH RePORTER · NIH · R01 · $83,267 · view on reporter.nih.gov ↗

Abstract

The present proposal is a continuation of our research into the pathogenesis and manipulation of adjuvant arthritis in Lewis rats using long-term lines and clones of T lymphocytes. Since the previous competitive reviewing we used clones A2b and A2c to probe expression libraries of MT antigens and discovered that both A2b and A2c recognized a 65KD protein of the BCG strains of MT. The epitope was identified as composed of 9 amino acids, position 180-188 in the sequence of the 65KD antigen. This sequence showed some homology with the link protein of cartilage proteolglycan. Thus we are in a position to identify the component of the joints cross-reactive with the MT nonapeptide. Immunization of Lewis rats with the purified 65KD protein induced resistance to subsequent attempts to trigger arthritis by immunization to whole MT in oil. We also succeeded in treating cells of clone A2b so that, similar to clone A2c, treated A2b could be used to vaccinate rats against adjuvant arthritis and to induce remission of established arthritis. Anti- idiotypic T cells were associated with resistance. The general aims of this proposal are to complete the characterization of the joint antigens recognized by clones A2b and A2c and by other functional T cell, and to elucidate the mechanism of resistance to arthritis induced by vaccination with such T cells. The specific aims are as follows: 1. Characterization of Joint Target Antigens a. Synthetic peptides homologous with the nonapeptide. b. Monoclonal antibody t specific MT antigens c. Affinity purification of cross-reactive tissue antigens. 2. Characterization of Functional T cells a. Responses in active arthritis b. Development of additional lines and clones c. Anti-idiotypic antibody probes d. T cell receptor genes 3. Mechanisms of T Cell Vaccination a. Treatment of established arthritis b. Vaccines prepared from arthritic rats. c. Passive transfer of vaccinated state. d. Anti-idiotypic T cells e. Effects of responses to antigens 4. Inhibition of arthritis using T cell defined epitopes

Key facts

NIH application ID
3156213
Project number
2R01AR032192-07
Recipient
WEIZMANN INSTITUTE OF SCIENCE
SAM.gov UEI
NPJ8YBLFTKX6
Principal Investigator
IRUN R COHEN
Activity code
R01
Funding institute
NIH
Fiscal year
1989
Award amount
$83,267
Award type
2
Project period
1983-04-01 → 1992-03-31